Cargando…

Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study

OBJECTIVE: To estimate the association between oncologists’ receipt of payments from the pharmaceutical industry and delivery of non-recommended or low value interventions among their patients. DESIGN: Cohort study. SETTING: Fee-for-service Medicare claims. PARTICIPANTS: Medicare beneficiaries with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Aaron P, Dusetzina, Stacie B, Mishra Meza, Akriti, Trivedi, Niti U, Bach, Peter B, Winn, Aaron N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599253/ https://www.ncbi.nlm.nih.gov/pubmed/37879723 http://dx.doi.org/10.1136/bmj-2023-075512

Ejemplares similares

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Endocrine Therapy Initiation among Older Women with Ductal Carcinoma In Situ
por: Anderson, Chelsea, et al.
Publicado: (2017)

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
por: Karanges, Emily Aspasia, et al.
Publicado: (2021)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Assessment of Expected Out-of-Pocket Spending for Rheumatoid Arthritis Biologics Among Patients Enrolled in Medicare Part D, 2010-2019
por: Erath, Alexandra, et al.
Publicado: (2020)

Facial plating industry payments: An analysis of the open payments database
por: Lorenz, F. Jeffrey, et al.
Publicado: (2023)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Pharmaceutical payments to Japanese certified hematologists: a retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Kusumi, Eiji, et al.
Publicado: (2022)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry
por: Debon, Aaron, et al.
Publicado: (2023)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Review of Industry Payments to General Orthopaedic Surgeons Reported by the Open Payments Database: 2014 to 2019
por: Braithwaite, Johann, et al.
Publicado: (2021)

Industry payments to physician journal editors
por: Wong, Victoria S. S., et al.
Publicado: (2019)

Trends of Industry Payments in Neurology Subspecialties
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Industry Payments to Nephrologists in the United States
por: Pakanati, Abhinandan R, et al.
Publicado: (2021)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Pharmaceutical Payments to Authors of Dermatology Guidelines After Publication
por: Sivesind, Torunn E, et al.
Publicado: (2022)

Association of Branded Prescription Drug Rebate Size and Patient Out-of-Pocket Costs in a Nationally Representative Sample, 2007-2018
por: Yeung, Kai, et al.
Publicado: (2021)

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Female dermatology journal editors accepting pharmaceutical payments: An analysis of the Open Payments database, 2013 to 2018
por: Haque, Waqas, et al.
Publicado: (2021)

Pharmaceutical payments to Japanese board-certified dermatologists: a 4-year retrospective analysis of personal payments from pharmaceutical companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2023)

Impact of US industry payment disclosure laws on payments to surgeons: a natural experiment
por: Rhee, Taeho Greg, et al.
Publicado: (2020)

Propensity Score Estimation to Address Calendar Time-Specific Channeling in Comparative Effectiveness Research of Second Generation Antipsychotics
por: Dusetzina, Stacie B., et al.
Publicado: (2013)

Out-of-Pocket Spending Not Associated with Oral Oncolytic Survival Benefit
por: Rotenstein, Lisa S., et al.
Publicado: (2018)

Concordance of Disclosed Hospital Prices With Total Reimbursements for Hospital-Based Care Among Commercially Insured Patients in the US
por: Horný, Michal, et al.
Publicado: (2021)

Monthly Cost-Sharing Limits and Out-of-pocket Costs for Commercially Insured Patients in the US
por: Shafer, Paul R., et al.
Publicado: (2022)

Pharmaceutical company payments to authors of the Japanese guidelines for the management of hypertension
por: Senoo, Yuki, et al.
Publicado: (2021)

Industry Payments Received by Residents During Training
por: Hogan, Sean O., et al.
Publicado: (2023)

Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
por: Nguyen, Andrew M., et al.
Publicado: (2022)

Mining Open Payments Data: Analysis of Industry Payments to Thoracic Surgeons From 2014-2016
por: Na, Xu, et al.
Publicado: (2018)

Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020
por: Kyle, Michael Anne, et al.
Publicado: (2022)

Medical Students' Exposure to and Attitudes about the Pharmaceutical Industry: A Systematic Review
por: Austad, Kirsten E., et al.
Publicado: (2011)

Evaluating the Correlation Between Various Orthopaedic Foot and Ankle Fellowship Characteristics and Total Industry Payments Through the Open Payments Database
por: Anastasio, Albert T., et al.
Publicado: (2023)

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
por: Sawano, Toyoaki, et al.
Publicado: (2019)

Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan
por: Murayama, Anju, et al.
Publicado: (2020)

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmhf7f7b29j5muar9leq5bjdv3